D-0387-2021 Class III Terminated

Recalled by Nomax Inc — Saint Louis, MO

FDA drug recall D-0387-2021 was initiated by Nomax Inc on Apr 13, 2021 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated Sep 28, 2023). Affected quantity: 78 cartons.

Recall details

Product Type
Drugs
Report Date
May 26, 2021
Initiation Date
Apr 13, 2021
Termination Date
Sep 28, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
78 cartons

Product description

Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100 Sterile Strips (50 Pouches of 2 Strips Each), Manufactured by: Nomax, Inc, St. Louis, MO 63123, NDC: 51801-008-15

Reason for recall

Subpotent Drug

Distribution pattern

Nationwide USA

Code information

LOT 13336 EXP 07/23

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0387-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0387-2021. Report a data issue: hello@regdatalab.com.